Literature DB >> 11833677

Molecular biology of partial D and weak D: implications for blood bank practice.

Willy A Flegel1, Franz F Wagner.   

Abstract

Two genes, RHD and RHCE, encode the antigens of the RH blood group system. The clinically most important antigen D is determined by the presence of a functional and grossly normal RHD gene. About 18% of Europeans do not express an antigen D, most often but not always caused by the RHD gene deletion. Rhesus negative phenotypes in Africans are caused by the RHD gene deletion, the RHD pseudogene RHD psi, and the Cde(s) allele. About 1% of Europeans carry RHD alleles with aberrant structures encoding for diminished D-immunoreactivity. In Africans the frequency of aberrant RHD alleles is much higher. Aberrant RHD alleles encode partial D, some of which were dubbed D categories, and weak D. Since we defined the molecular basis of the RHD deletion, a specific detection of heterozygous carriers became feasible.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11833677

Source DB:  PubMed          Journal:  Clin Lab        ISSN: 1433-6510            Impact factor:   1.138


  19 in total

Review 1.  Molecular genetics and clinical applications for RH.

Authors:  Willy A Flegel
Journal:  Transfus Apher Sci       Date:  2011-01-28       Impact factor: 1.764

2.  RHD allelic identification among D-Brazilian blood donors as a routine test using pools of DNA.

Authors:  Mariza Mota; M Dezan; M C Valgueiro; A M Sakashita; J M Kutner; L Castilho
Journal:  J Clin Lab Anal       Date:  2012-02       Impact factor: 2.352

3.  Forty years of anti-D immunoprophylaxis.

Authors:  Giorgio Reali
Journal:  Blood Transfus       Date:  2007-01       Impact factor: 3.443

4.  Survey on the prevention and incidence of haemolytic disease of the newborn in Italy.

Authors:  Francesco Bennardello; Giuseppe Curciarello
Journal:  Blood Transfus       Date:  2013-06-14       Impact factor: 3.443

5.  Weak D in the Tunisian population.

Authors:  Mouna Ouchari; Houda Romdhane; Taher Chakroun; Saida Abdelkefi; Batoul Houissa; Slama Hmida; Saloua Jemni Yacoub
Journal:  Blood Transfus       Date:  2014-10-23       Impact factor: 3.443

Review 6.  The Rhesus Site.

Authors:  Franz F Wagner; Willy A Flegel
Journal:  Transfus Med Hemother       Date:  2014-09-15       Impact factor: 3.747

7.  A simple diagnostic strategy for RhD typing in discrepant cases in the Indian population.

Authors:  Swati Kulkarni; Vasantha Kasiviswanathan; Kanjaksha Ghosh
Journal:  Blood Transfus       Date:  2012-07-12       Impact factor: 3.443

8.  Clinically relevant RHD-CE genotypes in patients with sickle cell disease and in African Brazilian donors.

Authors:  Ane C Gaspardi; Emília A Sippert; Mayra Dorigan De Macedo; Jordão Pellegrino; Fernando F Costa; Lilian Castilho
Journal:  Blood Transfus       Date:  2016-04-28       Impact factor: 3.443

9.  It's time to phase in RHD genotyping for patients with a serologic weak D phenotype. College of American Pathologists Transfusion Medicine Resource Committee Work Group.

Authors:  S Gerald Sandler; Willy A Flegel; Connie M Westhoff; Gregory A Denomme; Meghan Delaney; Margaret A Keller; Susan T Johnson; Louis Katz; John T Queenan; Ralph R Vassallo; Clayton D Simon
Journal:  Transfusion       Date:  2014-12-01       Impact factor: 3.157

10.  Systematic RH genotyping and variant identification in French donors of African origin.

Authors:  Sandrine Kappler-Gratias; Carine Auxerre; Isabelle Dubeaux; Marylise Beolet; Maryline Ripaux; Pierre-Yves Le Pennec; Bach-Nga Pham
Journal:  Blood Transfus       Date:  2013-06-17       Impact factor: 3.443

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.